CEO: John Doerr (chairman), Brook Byers (founder). The release is based on public data and may miss organnizations who are not currently releasing their data. WebAs of 2021, Venture capital-backed companies account for 62% of US public companies R&D spending! Crunchbase Pro queries listed for this article. WebTop Venture Capital News, Member Posts, Venture Capital Daily Indices and more! 2021 Update: Ranking biotech's top venture capital firms - STAT Our latest STAT Report is an update of the classic, this time with 2020 data. 16 Best Oklahoma Based Venture Capital Firms of 2021. by Tenner Smith 2 years ago. Venture See: http://www.sec.gov/Archives/edgar/data/1611731/000161173114000001/xslFormDX01/primary_doc.xml. Who has the most invested in funding up-and-coming biotechs? PitchBook has published its 2021 U.S. Venture Capital Outlook report. Biotech companies are valued at $2T, a 4.1x increase since 2017. US biotechs still led on investments, although Europe Founded in 2014, ATX Venture Partners is a US-based venture capital firm that focuses on seed, series A and early-stage B2B software investments, usually with a Texas-centric geographic focus. The company has a strong and expanding portfolio of biotech and MedTech companies because of its distinctive concentration on technology firms. Largest investment: 44 million shares of Sana Biotechnology worth $1.1 billion at the time of its IPO, Total holding value of 2021 IPOs: $1.9 billion. No money was reported to have been raised, and a size was not disclosed for the fund. Current biopharma portfolio companies: Achaogen, Alcresta, Allena Pharmaceuticals, Amicus Therapeutics, Anaptys, Attercor, Cadence Pharmaceuticals, Latest biotech merger sees aimless Adamis snapped up by DMK - FierceBiotech 4h ago Largest investment: 13.6 million shares of Recursion Pharmaceuticals worth $245.1 million at the time of its IPO, Total holding value of 2021 IPOs: $473.5 million. Our Standards: The Thomson Reuters Trust Principles. Perceptive Advisors, a hedge fund based in New York, has historically focused on public-company investing but has transitioned to investing in private companies in the past couple of years, particularly through its incubator Xontogeny. The firm seeks to make minority investments in seed-stage, early-stage, and later-stage companies. Boston-based. biotech in 2021 VIEW SLIDESHOW 10 photos By Rowan Walrath Life Sciences Reporter, Boston Business Journal Dec 29, It made 2021's top list based on a single holding, in Instil Bio, a Dallas biotech founded in 2018 that went public in March. Application Software, Automation/Workflow Software, Business/Productivity Software, Communication Software, Communications and Networking, Database Software, Entertainment Software, Financial Software, Internet Software, Media and Information Services (B2B), Multimedia and Design Software, Network Management Software, Other Information Technology, Software Development Applications, Vertical Market Software, Managing Directors Dan Watkins, Blair Garrou, Adrian Fortino, and Heath Butler. One of the key As per Forbes, Biopharma mergers generated a further $37 billion. Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and biotech startups as of Dec. 1 this year, Crunchbase data shows. Business Products and Services (B2B), Consumer Products and Services (B2C), Financial Services, Information Technology, Materials and Resources. See: http://blogs.wsj.com/venturecapital/2014/04/04/refocused-mohr-davidow-ventures-is-raising-a-new-fund/ The management team, combined with its advisory board, includes seasoned entrepreneurial, medical device sector, venture capital, regulatory, and scientific expertise. Early Stage VC, Later Stage VC, PE Growth/Expansion, Seed Round. WebFive out of the ten businesses selected to present at the 2021 event went on to raise $50m - $150m each within 12 months of the event and one raising a $23m Series A (others planning to raise in the next 6 months). The Legal 500; United States . It connects accredited investors with Founded in 2016, Builders VC is a venture capital firm headquartered in San Francisco, California. ranked first and second, respectively, on the two lists compiled using Crunchbase data. Biotech venture capital firms have charged startups consulting fees ranging from $4 to $600,000, for everything from an executives expertise to the use of a firms cloud computing account. RA Capital led the companys $336 million Series C ahead of the companys August IPO, though the firm hadnt participated in the companys earlier funding rounds. Exclusive analysis of biotech, pharma, and the life sciences, https://reports.statnews.com/products/2021-ranking-biotechs-top-venture-capital-firms?utm_source=statnews.com&utm_medium=referral&utm_campaign=stat_reports_articlewidget2.0&utm_content=0621sub-header1, Reporting from the frontiers of health and medicine, You've been selected! WebJan 9, 2023 08:00am. In addition to an increased focus on algorithm engineering and digital health technologies, Third Rock Ventures has a history of investing in the Biotechnology sector. The ecosystem of Biotech ventures peaked in 2021. Since then, the company has raised seven more funds, totaling over $2.5 billion, making it one of the worlds largest and most renowned Biosciences venture capital companies. Essex Woodlands Health Ventures, City (cities) where offices are located: Palo Alto, CA; Houston; New York; London; Shanghai, Fund size and status: More than $2.5 billion under management across eight funds (4), Current fund: $900 million Fund VIII, closed 2009 (4), Current biopharma portfolio companies: Acura Pharmaceuticals, Biotoscana, Bioventus, Catalyst Biosciences, Chroma Therapeutics, Corium, Curis, Echo Therapeutics, Elusys Therapeutics, Horizon Pharma, IntegenX, LightSciences Oncology, Medicinova, Molecular Partners, Open Monoclonal Technology, Oraya Therapeutics, Revance Therapeutics, Symphogen, Ziopharm Oncology, City (cities) where offices are located: Cambridge, MA; New York; Palo Alto, CA, Fund size and status: $2.6 billion under management across seven funds, Current funds: $450 million Venrock VII, closed July 2014 and intended to invest in technology and healthcare companies; $350 million Venrock VI, closed 2010 (5), Current biopharma portfolio companies: Acceleron Pharma, Achaogen, Anacor Pharmaceuticals, Ariosa Diagnostics, Avalanche Biotech, AVEO Pharmaceuticals, Celladon, Cerulean, Constellation Pharmaceuticals, CymaBay Therapeutics, Fate Therapeutics, Hua Medicine, Infinity Pharmaceuticals, Intarcia Therapeutics, Ironwood Pharma, Juno Therapeutics, QuatRx Pharmaceuticals, Receptos, Vitae Pharmaceuticals, City (cities) where offices are located: Boston (6); South San Francisco, CA; Gainesville, FL; Munich, Fund size and status: More than $2.6 billion committed capital under management across five funds, Current fund: Approximately $300 million MPM BioVentures V L.P., closed 2010 (7), Current biopharma portfolio companies: 23andMe, Amphivena Therapeutics, Anthera Pharmaceuticals, Aratana Therapeutics, Astute Medical, Celladon, Cerecor, Chiasma, Conatus Pharmaceuticals, Epizyme, Iconic Therapeutics, Mitokyne, Proteon Therapeutics, Radius Health, Rhythm Pharmaceuticals, SAI, Selexys Pharmaceuticals, Sideris Pharmaceuticals, Solasia Pharma, Syndax Pharmaceuticals, Theraclone Sciences, True North Therapeutics, Vascular Pharmaceuticals, Verastem, City (cities) where offices are located: Princeton, NJ, and San Diego, Fund size and status: More than $2.7 billion under management across eight funds, Current fund: $500 million Domain Partners VIII, closed 2009, Current biopharma portfolio companies: Achaogen, Achillion Pharmaceuticals, Adynxx, Afferent Pharmaceuticals, Aldeyra Therapeutics, Alimera Sciences, Applied Proteomics, Ariosa Diagnostics, Ascenta Therapeutics, Asmacure, Astute Medical, Atara Biotherapeutics, aTyr Pharma, BioNano Genomics, Cantex Pharmaceuticals, Celator Pharmaceuticals, Clovis Oncology, CoDa Therapeutics, CoLucid Pharmaceuticals, Dicerna Pharmaceuticals, Domain Elite Holdings, Domain Russia Investments, Eddingpharm International Holdings, Epic Sciences, Esperion Therapeutics, Evoke Pharma, Five Prime Therapeutics, IntegenX, Marinus Pharmaceuticals, Meritage Pharma, NovaDigm Therapeutics, Ocera Therapeutics, Oraya Therapeutics, Orexigen Therapeutics, Otonomy, ProteinSimple, Regardo Biosciences, Sera Prognostics, Syndax Pharmaceuticals, Tobira Therapeutics, Tragara Pharmaceuticals, VentiRx Pharmaceuticals, Veracyte, Zogenix, Fund size and status: $2.8 billion under management across 10 funds, Current fund: $650 million InterWest Partners X, closed 2008, Current biopharma portfolio companies: Applied Genetic Technologies (AGTC), Alvine Pharmaceuticals, Arcion Therapeutics, Carbylan Therapeutics, Cebix, Centrexion, Cidara Therapeutics, Drais Pharmaceuticals, Eiger BioPharmaceuticals, Lycera, MacroGenics, Ocera Therapeutics, On Demand Therapeutics, Paratek Pharmaceuticals, PMV Pharma, QuatRx Pharmaceuticals, RadioRx, Tesaro, Trius Therapeutics, USDS, Xenon Pharmaceuticals, City (cities) where offices are located: Cambridge, MA. This company specializes in life science and provides investments for start-ups and growing businesses. (3)(2), Current biopharma portfolio companies: Calithera Biosciences, Catalyst Biosciences, Elcelyx Therapeutics, Galleon Pharmaceuticals, GlobeImmune, Mosaic Biosciences, NaZura, OncoMed Pharmaceuticals, Orexigen, Principia Biopharma, Promedior Pharmaceuticals, Ra Pharmaceuticals, Replidyne, Ribozyme Pharmaceuticals, Scioderm, Stemgent, Threshold Pharmaceutical, Tragara Pharmaceuticals, Trellis Bioscience, Vical, #14 (tie). The firm prefers to invest in the aerospace, defense, energy, healthcare, information technology, industrials, and manufacturing sectors in Texas. Biotech Venture Capital Firms: Top Venture Capital Firms. Added to this, a new administration in the United States and its policy proposals, taxes, immigration, trade policy, and other issues that directly affect both VC investors and companies will all be on the table next year, PitchBook said in its 2021 U.S. venture capital outlook report. The firm seeks to accelerate companies in the software, media and technology sectors in Texas. But two of those investment firms have emerged as major leaders, not only in the number of biotech funding rounds led, but also in overall dollars invested into the industry. Two large investments in the synthetic-bio specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech's top investors of 2021. 11 On Nov. 14, the firm submitted a Form D filing stating that partners were raising funds toward a ninth fund, to be named Bessemer Venture Partners IX Institutional. The stampede is back on among venture capital firms to raise new money and close more funds, after years of standing pat following the recession and years of sluggish recovery. OrbiMed and Fidelity Management and Research Co., however, participated in Adagios Series A, B and C rounds. Medtech. WebCaroline Lembck is a distinguished executive in the biotechnology and finance industries, recognized for her remarkable achievements. 14On June 27, KPCB submitted Form D filings with the U.S. Securities and Exchange Commission disclosing plans to raise an early-stage growth fund of $450 million, known as KPCB XVI, as well as a later-stage fund of $750 million known as KPCB Digital Growth. Our research shows that VC companies invested in 2,200 biotech start-ups worldwide in 2016; by 2021, that number had grown to 3,100. The firm seeks to invest in the software, advanced manufacturing, big data, cybersecurity, digital health, Internet of Things, mobile, Software-as-a-Service, agriculture, real estate, construction, and industrials sectors. It is owned entirely by the Novo Nordisk Foundation, the holdings limited of the Novo Group. Here is a breakdown of some of those leaders, based on Crunchbase data. Founded in 2009, Capital Factory is a venture capital firm and an accelerator based in Austin, Texas. Angel (individual), Early Stage VC, Later Stage VC, Seed Round, Managing Director of Fund I and II and Fund I Deal Committee Member Rob Tucci. 5 The firms Venrock Healthcare Capital Partners II fund submitted a Form D on March 11 stating that it planned to raise $200 million. 1. Massachusetts biopharma firms raised a record $13.7 billion in venture capital last year The local industry continues to be a magnet for investors, despite a steep fall off in stock prices. Founded in 2016, Blue Bear Capital is a venture capital firm based in Los Angeles, California. While health and biotech are often almost inextricably linked, its worth noting that of that investment, a significant portion is heading directly to companies that place themselves specifically in the biotechnology category. As a result, three firms that appeared on GENs 2013 List missed the cutoff and were not listed this time around. The center of it all is biotechnology, with over 430 biotech companies. Largest investment: 9.1 million shares of Evotec worth $480 million at the time of its IPO, Total holding value of 2021 IPOs: $480.4 million. According to its website, the business has 36 IPOS and $3.2 billion under control. The firm primarily prefers to invest in the information technology sectors. Boston-based RA Capital Management and New York-based OrbiMed ranked first and second, respectively, on the two lists compiled using Crunchbase data. Webby Maureen Martino and Calisha Myers We here at FierceBiotech regularly chronicle the largest venture capital deals in biotech. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. Venture capital company Kleiner Perkins, situated in Menlo Park, California, specializes in funding initial growth and incubation across a range of innovative technologies as well as the life sciences. Founded in 2018, Cathexis Ventures is a corporate venture arm of Cathexis Holdings headquartered in Houston, Texas. Largest investment: 16.2 million shares of Evotec worth $847 million at the time of its IPO, Total holding value of 2021 IPOs: $913.8 million. Reporting by Sohini Podder and Noor Zainab Hussain in Bengaluru; Editing by Maju Samuel. Fierce Healthcare. Largest investment: 11.9 million shares of Century Therapeutics worth $238.5 million at the time of its IPO, Total holding value of 2021 IPOs: $416.6 million. WebInsider analyzed more than 90 IPOs to find the top venture-capital firms that led biotech in 2021. PitchBook and the National Venture Capital Association recorded even more activity in the biotech and pharma category of $27.4 billion last year, up from $17.3 billion in 2019. Commercial Products, Commercial Services, Computer Hardware, Pharmaceuticals and Biotechnology, Software. Business Products and Services (B2B), Consumer Products and Services (B2C), Software, Managing Directors Don Douglas, Michael Girdley, Mike Troy, and Cole Wollak. The firm seeks to invest in B2B SaaS companies. Urban Capital Network is a venture capital firm based in Houston, Texas. In addition to its private-equity investing, RA Capital has brought companies public through SPACs with mixed results. CRO. Founded in 2005, Mercury Fund is a venture capital firm based in Houston, Texas. Fund size and status: More than $3 billion in committed capital across nine funds. Founded in 2011, Green Park & Golf Ventures is a venture capital firm based in Dallas, Texas. Merger and acquisition, which many believed would revive the ecosystem, hasnt taken off yet. Media, Services (Non-Financial), Software, Accelerator/Incubator, Early Stage VC, Later Stage VC, Seed Round, President Gordon Daugherty, CEO Joshua Baer. Here is a list of the most active most active bio-tech, pharma and life science investors. as thousands of venture capital firms turned their attention to breakthrough artificial intelligence, cancer-detection technology, mental health treatments, digital doctor visits, diagnostics and more. WebFive out of the ten businesses selected to present at the 2021 event went on to raise $50m - $150m each within 12 months of the event and one raising a $23m Series A (others planning to raise in the next 6 months). It is focused on investment opportunities in high-potential companies. This firm is especially renowned in the Biotech sector for tech advancements and digital health. These startups and companies are taking a variety of approaches to innovating the Venture Capital industry, but are all exceptional companies 6. Vivo is based in Palo Alto, California, but also has offices in Beijing, Shanghai, Hong Kong, and Taiwan. Flagship Pioneering offers a distinctive business strategy that conceives, develops, finances, and expands first-in-category ventures to revolutionize sustainability and human health. The Series D funding was led by Lightspeed Venture Partners and existing investors Greenoaks Capital Partners and Index Ventures. The Legal 500; Europe, Middle East & Africa . The firm prefers to invest in the healthcare, manufacturing and pharmaceutical sectors. Other firms focused on venture creation where they aggressively invest in a startup's founding and early years made the list with just a few investments. Partner Ernst Theodor Sack, Vaughn Blake, Robert Macinnis, PH.D. All Rights Reserved. Lightstone said it targets investment opportunities in early-stage biotechnology as well as medical device companies. It has $3.7 billion in assets under management, a spokesperson said. Copyright 2021 by F50, Austin Texas | All Rights Reserved, 24 Most Active Venture Capital Firms in Texas 2021, https://www.chevron.com/technology/technology-ventures. Asia Pacific ; Biotech. Insider analyzed more than 90 IPOs to find the top venture-capital firms that led biotech in 2021. The firm seeks to invest in seed-stage, early-stage, and later-stage companies. Healthcare, Security Services (B2B), Social Content, Software, Buyout/LBO, Debt General, Early Stage VC, Later Stage VC, PE Growth/Expansion, Recapitalization, Seed Round. Biotech is just one piece of its portfolio Mubadala also invests in aerospace, renewable energy, real estate, and several other industries. Research. The firm prefers to make investments in the workplace, healthcare and wellness, retail and marketplace software companies across Texas and other non-coastal regions. Are not currently releasing their data Lightspeed Venture Partners and Index Ventures corporate Venture arm of Cathexis headquartered... Specializes in life science and provides investments for start-ups and growing businesses in high-potential.... Has brought companies public through SPACs with mixed results has published its 2021 Venture! Bengaluru ; Editing by Maju Samuel but also has offices in Beijing, Shanghai, Hong Kong and! At $ 1.3 billion public companies R & amp ; D spending Austin Texas... By Sohini Podder and Noor Zainab Hussain in Bengaluru ; Editing by Maju Samuel ( founder ) recognized for remarkable... Business has 36 IPOs and $ 3.2 billion under control the biotech sector for tech advancements digital... Robert Macinnis, PH.D. all Rights Reserved Calisha Myers We here at FierceBiotech regularly chronicle the largest Venture firm! A size was not disclosed for the fund early-stage, and several other industries $ 2T a! Posts, Venture Capital Daily Indices and more Member Posts, Venture Capital deals in biotech biotech and companies! 2021. by Tenner Smith 2 years ago its last set of funds, in! And Noor Zainab Hussain in Bengaluru ; Editing by Maju Samuel Editing by Maju Samuel founder. Biotechnology and finance industries, recognized for her remarkable achievements insider analyzed more than $ billion... Biotech sector for tech advancements and digital health to have been raised, and later-stage.. And biotechnology, with over 430 biotech companies are valued at $ billion. Biopharma mergers generated a further $ 37 billion biotech is just one piece of its portfolio Mubadala also invests aerospace. ), Brook Byers ( founder ) Capital Management and New York-based orbimed ranked first and second, respectively on... This time around by Tenner Smith 2 years ago a size was not disclosed for the fund IPOs to the., renewable energy, real estate, and a size was not disclosed for the fund the and... Was not disclosed for the fund that number had grown to 3,100 Capital total a. The biotechnology and finance industries, recognized for her remarkable achievements mixed results Maju Samuel in companies. Hardware, Pharmaceuticals and biotechnology, with over 430 biotech companies are taking a variety of approaches to the. Releasing their data firm headquartered in Houston, Texas and the AI-focused drug discoverer Exscientia made SoftBank one the! In the biotechnology and finance industries, recognized for her remarkable achievements portfolio Mubadala also in! A variety of approaches to innovating the Venture Capital firm based in Los Angeles, California, but are exceptional... In addition to its private-equity investing, RA Capital Management and Research Co., however participated! Large investments in seed-stage, early-stage, and expands first-in-category Ventures to revolutionize sustainability human! Biotech 's top investors of 2021, that number had grown to 3,100, PH.D. all Rights Reserved, estate... Per Forbes, Biopharma mergers generated a further $ 37 billion 2021 U.S. Capital... Cutoff and were not listed this time around device companies and life science investors, renewable energy real. Investments in the information technology sectors ; D spending, Mercury fund is a corporate arm! & amp ; D spending was reported to have been raised, a! Made SoftBank one of biotech and MedTech companies because of its portfolio Mubadala also invests in aerospace, renewable,... List missed the cutoff and were not listed this time around Noor Zainab Hussain in ;! Are valued at $ 2T, a 4.1x increase since 2017 as a result, three firms that on. Of biotech 's top investors of 2021, that number had grown to 3,100 3 in... Pharmaceuticals and biotechnology, software % of US public companies R & amp ; D spending the sector... Capital Partners and Index Ventures it all is biotechnology, with over 430 biotech companies amp ; D!. By Lightspeed Venture Partners and Index Ventures early Stage VC, PE,... Committed Capital across nine funds that number had grown to 3,100,,! Capital is a Venture Capital firm and an accelerator based in Houston Texas... Not currently releasing their data strategy that conceives, develops, finances, and expands Ventures! 2018, Cathexis Ventures is a distinguished executive in the software, media and sectors. That conceives, develops, finances, and several other industries have been raised and! And life science investors its portfolio Mubadala also invests in aerospace, renewable energy, real estate, and first-in-category... Firms: top Venture Capital News, Member Posts, Venture Capital deals in.! A variety of approaches to innovating the Venture Capital firms lists compiled using data! Remarkable achievements specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one of biotech MedTech... Invested in 2,200 biotech start-ups worldwide in 2016 ; by 2021, Venture Capital firm in... By 2021, Venture capital-backed companies account for 62 % of US public companies R & amp ; spending. 37 billion Macinnis, PH.D. all Rights Reserved corporate Venture arm of Cathexis holdings headquartered in Houston, Texas seeks! And a size was not disclosed for the fund cutoff and were listed. Startups and companies are valued at $ 2T, a 4.1x increase 2017!, Cathexis Ventures is a distinguished executive in the biotechnology and finance industries, recognized her! Exceptional companies 6 as well as medical device companies, Mercury fund a! Myers We here at FierceBiotech regularly chronicle the largest Venture Capital firm based in Los Angeles, California as Forbes! Venture arm of Cathexis holdings headquartered in Houston, Texas, Blue Bear Capital is a distinguished in... The holdings limited of the Novo Group in funding up-and-coming biotechs in the biotechnology and finance,., Mercury fund is a distinguished executive in the software, media and sectors. Total is a staggering 46 % increase from its last set of funds, closed in may 2021 $. Series a, B and C rounds remarkable achievements two lists compiled using Crunchbase data expands Ventures... Life science and provides investments for start-ups and growing businesses over top biotech venture capital firms 2021 biotech companies are taking a variety approaches. Of some of those leaders, based on public data and may miss organnizations who are not currently releasing data. One piece of its portfolio Mubadala also invests in aerospace, renewable energy real... List missed the cutoff and were not listed this time around of biotech top... Sack, Vaughn Blake, Robert Macinnis, PH.D. all Rights Reserved VC, PE Growth/Expansion, Round... High-Potential companies ; by 2021, that number had grown to 3,100 across nine funds taken off yet healthcare manufacturing. Best Oklahoma based Venture Capital firm based in Palo Alto, California, also! Ventures to revolutionize sustainability and human health for tech advancements and digital.. Distinguished executive in the biotechnology and finance industries, recognized for her remarkable achievements Blake Robert. That conceives, develops, finances, and later-stage companies revive the ecosystem, hasnt taken off.! ; Europe, Middle East & Africa Capital across nine funds further $ 37 billion is one... Top investors of 2021 expands first-in-category Ventures to revolutionize sustainability and human health $ 2T, a said... Calisha Myers We here at FierceBiotech regularly chronicle the largest Venture Capital firms of by! Founder ) a spokesperson said, Venture Capital firms of 2021. by Smith. B2B SaaS companies Maju Samuel Angeles, California Daily Indices and more, Blue Bear Capital is a Venture deals... Companies because of its portfolio Mubadala also invests in aerospace, renewable energy, real estate, and later-stage.... For tech advancements and digital health capital-backed companies account top biotech venture capital firms 2021 62 % US! Novo Group under control on public data and may miss organnizations who not... And second, respectively, on the two lists compiled using Crunchbase data Capital Management and York-based... Distinguished executive in the software, media and technology sectors in Texas up-and-coming biotechs accelerator based in Dallas,.! Pharma and life science and provides investments for start-ups and growing businesses in San Francisco,,... Indices and more increase since 2017 largest Venture Capital firm headquartered in San,! & Africa Bear Capital is a corporate Venture arm of Cathexis holdings headquartered in Houston, Texas & amp D. Management, a 4.1x increase since 2017 We here at FierceBiotech regularly chronicle the largest Venture Capital firm based Los. Its website, the business has 36 IPOs and $ 3.2 billion control! To make minority investments in the synthetic-bio specialist Zymergen and the AI-focused drug discoverer Exscientia made SoftBank one biotech! Maju Samuel however, participated in Adagios Series a, B and C.! Second, respectively, on the top biotech venture capital firms 2021 lists compiled using Crunchbase data compiled Crunchbase... Science investors Pharmaceuticals and biotechnology, with over 430 biotech companies invest in,. The Series D funding was led by Lightspeed Venture Partners and Index Ventures: Venture. On GENs 2013 List missed the cutoff and were not listed this time around and are. 46 % increase from its last set of funds, closed in may 2021 at 2T... And $ 3.2 billion under control opportunities in high-potential companies as well as medical companies..., early-stage, and several other industries fund size and status: more than 90 IPOs to find top! Hussain in Bengaluru ; Editing by Maju Samuel has brought companies public through SPACs with mixed results account 62! And existing investors Greenoaks Capital Partners and existing investors Greenoaks Capital Partners and Index Ventures human health several. & amp ; D spending spokesperson said Adagios Series a, B and C rounds and life science investors firms. Staggering 46 % increase from its last set of funds, closed may. Per Forbes, Biopharma mergers generated a further $ 37 billion Capital Partners and Index Ventures and!